
先端医療ベンチャー(週刊東洋経済eビジネス新書No.309)
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
$0.00 for first 30 days
LIMITED TIME OFFER
$0.99/mo for the first 3 months
Offer ends April 30, 2025 at 11:59PM PT.

Pick 1 audiobook a month from our unmatched collection.
Listen all you want to thousands of included audiobooks, Originals, and podcasts.
Access exclusive sales and deals.
Premium Plus auto-renews for $14.95/mo after 3 months. Cancel anytime.
Pick 1 audiobook a month from our unmatched collection.
Listen all you want to thousands of included audiobooks, Originals, and podcasts.
Access exclusive sales and deals.
Premium Plus auto-renews for $14.95/mo after 30 days. Cancel anytime.
Buy for $5.79
No default payment method selected.
We are sorry. We are not allowed to sell this product with the selected payment method
Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice. Taxes where applicable.
-
Narrated by:
-
海老塚 久蔵
-
By:
-
週刊東洋経済編集部
About this listen
2018年、世界のベンチャーキャピタルによるバイオテクノロジー分野への投資額は約1・7兆円に達し、10年で7倍近くに膨らんだ。ゲノム解読費用が急減し、ビッグデータの活用で、患者一人ひとりに合わせた医療を提供する「プレシジョン・メディシン」の到来だ。製薬業界でもバイオベンチャーが開発した遺伝子治療薬やウイルス製剤などが希少疾患で成果を上げ、M&Aや提携も活発化している。次世代における医療の覇者は誰か。最先端ベンチャーを通して、未来をのぞく。
本誌は『週刊東洋経済』2019年4月20日号掲載の26ページ分を電子化したものです。©東洋経済新報社 (P)2020 Audible, Inc.
adbl_web_global_use_to_activate_webcro768_stickypopup